Skip to main content
OpenTrials
Completed

NCT Number: NCT02023814

Peripheral Blood CD34-positive Cells Enumeration as Predictor of Stem Cell Harvest

Stem cell mobilization procedures after chemotherapy and G-CSf performed at our Institution between 2002 and 2013 were reviewed in order to define prognostic factors for optimal harvest

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Stem Cell Harvest Failure

Age range

16 year–75 year

Sex eligibility

All sexes

Study type

Observational

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Mobilization with chemotherapy and G-CSF
  • Years 2002-2013

Exclusion criteria

  • mobilization with G-CSF alone
  • mobilization with plerixafor

Treatment and study plan

Primary outcomes

  1. Blood Stem cell harvest failure rate

    Time frame: 7 days from hematological recovery

    Patients not able to harvest at least 2x10e6 CD34+/Kg in the specified time frame are considered failures

Sponsors and collaborators

Lead sponsor

Ospedale Santa Croce-Carle Cuneo

Other

Registry information

Official study title

Peripheral Blood CD34+ Cells Count as Predictor of Stem Cell Harvest After Chemotherapy and G-CSF. A Single Center Experience

Important dates

Study start
2002
Primary completion
2013
Study completion
2013
First posted
Dec 30, 2013
Registry last updated
Dec 30, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.